HIMS logo

Hims & Hers Health, Inc. Stock Price

NYSE:HIMS Community·US$7.3b Market Cap
  • 9 Narratives written by author
  • 11 Comments on narratives written by author
  • 1089 Fair Values set on narratives written by author

HIMS Share Price Performance

US$31.59
-18.39 (-36.79%)
US$173.02
Fair Value
US$31.59
-18.39 (-36.79%)
81.7% undervalued intrinsic discount
US$173.02
Fair Value
Price US$31.59
Deep_Insights US$173.02
jorgevalverde2366 US$68.00
AnalystConsensusTarget US$28.42

HIMS Community Narratives

Fair Value
·
Fair Value US$173.02 81.7% undervalued intrinsic discount

Hims & Hers Health Multidimensional Revenue Expansion

10users have liked this narrative
0users have commented on this narrative
60users have followed this narrative
·
Fair Value US$68 53.5% undervalued intrinsic discount

A Digital Healthcare Company Leader

2users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$28.42 11.1% overvalued intrinsic discount

Telehealth And Hormonal Health Will Transform Global Markets

12users have liked this narrative
0users have commented on this narrative
265users have followed this narrative
US$173.02
81.7% undervalued intrinsic discount
Fair Value
Revenue
36.3% p.a.
Profit Margin
10%
Future PE
60x
Price in 2030
US$242.66
US$68
53.5% undervalued intrinsic discount
Profit Margin
7.19%
Future PE
20.53x
Price in 2031
US$95.87
US$50.07
36.9% undervalued intrinsic discount
Fair Value
Revenue
37% p.a.
Profit Margin
6.05%
Future PE
26.92x
Price in 2031
US$70.16
US$17.15
84.2% overvalued intrinsic discount
Profit Margin
1%
Future PE
20x
Price in 2029
US$25.13
US$86.09
63.3% undervalued intrinsic discount
Fair Value
Revenue
22% p.a.
Profit Margin
15%
Future PE
50x
Price in 2030
US$138.65
US$28.42
11.1% overvalued intrinsic discount
Profit Margin
3.79%
Future PE
40.95x
Price in 2029
US$34.85

Trending Discussion

No trending discussion available.

Updated Narratives

HIMS logo

Hims is following the growth playbook

Fair Value: US$173.02 81.7% undervalued intrinsic discount
60 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HIMS logo

A Digital Healthcare Company Leader

Fair Value: US$68 53.5% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HIMS logo

FY2025

Fair Value: US$29.21 8.1% overvalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Exceptional growth potential and good value.

1 Risk
2 Rewards

Hims & Hers Health, Inc. Key Details

US$2.4b

Revenue

US$641.8m

Cost of Revenue

US$1.7b

Gross Profit

US$1.7b

Other Expenses

-US$13.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 10, 2026
-0.057
72.92%
-0.56%
218.3%
View Full Analysis

About HIMS

Founded
n/a
Employees
2442
CEO
Andrew Dudum
WebsiteView website
www.hims.com

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Recent HIMS News & Updates

New Narrative Jul 30

A Digital Healthcare Company Leader

Hims & Hers Health (NYSE: HIMS) Equity Research Report Intrinsic Valuation Analysis (5-Year Outlook) Investment Thesis We believe Hims & Hers Health remains one of the most compelling long-term growth stories in digital healthcare. The company has successfully transitioned from a niche direct-to-consumer telehealth platform into a diversified healthcare ecosystem with expanding offerings across primary care, mental health, dermatology, sexual health, women's health, and obesity management.

Recent updates

No updates